Spruce Biosciences (SPRB) Stock Statistics & Valuation Metrics

Spruce Biosciences has a market cap or net worth of $12.02M. The enterprise value is -$37.21M.

Spruce Biosciences has 41.30M shares outstanding. The number of shares has decreased by -2.65% in one year.

Spruce Biosciences’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Spruce Biosciences is -2.35. Spruce Biosciences’s PEG ratio is 0.07.

In the last 12 months, Spruce Biosciences had revenue of $7.10M and earned -$39.43M in profits. Earnings per share was -$0.95.

In the last 12 months, operating cash flow was -$46.50M and capital expenditures $0.00, giving a free cash flow of -$46.50M billion.

Spruce Biosciences pays an annual dividend of , resulting in a dividend yield of

Spruce Biosciences upcoming earnings date is May 7, 2025, After Close.

Spruce Biosciences as a current ratio of 4.18, with Debt / Equity ratio of 0.06

In the past 12 months, Spruce Biosciences has paid -$991.28K in taxes.

Spruce Biosciences EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Spruce Biosciences has $60.05M in cash and marketable securities with $3.23M in debt, giving a net cash position of -$56.83M billion.

Gross margin is -389.96%, with operating margin of -515.34%, and net profit margin of -474.96%.

The average price target for Spruce Biosciences is $1.25, which is 11.43% higher than the current price. The consensus rating is Hold